Drawing for NIGHT FEVER

USPTO serial 79329519

NIGHT FEVER

Reviewed by CopyMark Law Group

Reg. 7574572Status 700Registered
Filing date
Status date
Registration date
Nov 26, 2024
Examiner
ANGOTTI, SALVATORE JOHN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NIGHT FEVER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary Margaret L. O'Donnell

Mary Margaret L. O'Donnell Blue Filament Law PLLC772 E. Maple RoadBirmingham, MI 48009United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, dietetic foods adapted for medical use, dietetic substances adapted for paramedical use which may contain proteins, carbohydrates, lipids and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; pharmaceutical preparations, parapharmaceutical products and food supplements for medical and paramedical use, namely, pharmaceutical preparations, parapharmaceutical products and food supplements for medical and paramedical use which may contain proteins, carbohydrates, lipids and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; pharmaceutical preparations and parapharmaceutical products made from plants, extracts of plants and vegetable extracts in effervescent and other forms for enhancing energy production in the body; pharmaceutical preparations and parapharmaceutical products containing minerals and vitamins in effervescent and other forms; vitamins and minerals in effervescent and other forms, namely, granules; pharmaceutical preparations and parapharmaceutical products for phytotherapy; food supplements for medical use as additions to the nutrient intake in a normal diet; nutritional supplements for paramedical use for enhancing energy production in the body as additions to the nutrient intake in a normal diet, which may contain proteins, carbohydrates, lipids and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; all dietetic substances adapted for medical and paramedical use which may contain proteins, carbohydrates, lipids and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; food supplements for medical use prepared for human consumption from food ingredients of vegetable and mineral origin; nutritional supplements for paramedical use prepared for human consumption from food ingredients of vegetable and mineral origin, which may contain proteins, carbohydrates, lipids, and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; fortifying foodstuffs for medical use; fortifying foodstuffs for paramedical use which may contain proteins, carbohydrates, lipids and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the bodyACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 4, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 4, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 4, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 4, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 27, 2026RNWLINTERNATIONAL REGISTRATION RENEWED
Jul 2, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
May 9, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Apr 18, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB
Apr 18, 2025FIMPFINAL DISPOSITION PROCESSED
Feb 26, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 26, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 24, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 4, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 10, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 24, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 24, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 22, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 9, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 9, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 9, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 9, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 11, 2022RFNTREFUSAL PROCESSED BY IB
Nov 21, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 21, 2022RFRRREFUSAL PROCESSED BY MPU
Sep 20, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 19, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2022DOCKASSIGNED TO EXAMINER
Jan 7, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Jan 3, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 27, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance